Healthy volunteer group:N/A

3 trials

Sponsors

Hospital of Chengdu University of Traditional Chinese Medicine, Wuhan Jinyintan Hospital

Conditions

COVID-19Psoriasis Vulgaris

Early Phase 1

The mechanism of Supplemented Liang Xue Xiao Feng Powder(SLXXFP) adjusting blood-heat syndrome psoriasis vulgaris(PV) apoptosis by miR-203-SOCS3-JAK2/STAT3 double-inhibitory pathway

RecruitingITMCTR2000004112

Hospital of Chengdu University of Traditional Chinese MedicinePsoriasis Vulgaris

Start: 2020-09-23Updated: 2023-02-20

The mechanism of Supplemented Liang Xue Xiao Feng Powder(SLXXFP) adjusting blood-heat syndrome psoriasis vulgaris(PV) apoptosis by miR-203-SOCS3-JAK2/STAT3 double-inhibitory pathway

RecruitingChiCTR2000038591

Hospital of Chengdu University of Traditional Chinese MedicinePsoriasis Vulgaris

Start: 2020-09-23Updated: 2020-11-30

Unknown Phase

Follow-up assessment of patients with COVID-19 by using multinuclear MRI

Active, not recruitingChiCTR2300067776

Wuhan Jinyintan HospitalCOVID-19

Start: 2023-03-10Updated: 2023-05-15